Medical devices, healthcare technology and the business of care
510(k) clearance · K261313

Vivid Explorer/Vivid Advanced/Vivid Focus

GE Medical Systems Ultrasound and Primary Care Diagnostics · Decision date Sep 2, 2026

MEDTECHLEDGER EXPLANATIONK261313

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 2, 2026 for K261313, covering the GE Medical Systems Ultrasound and Primary Care Diagnostics diagnostic ultrasound systems marketed as Vivid Explorer, Vivid Advanced and Vivid Focus. The submission is a traditional 510(k) under 21 CFR 892.1550 (Ultrasonic Pulsed Doppler Imaging System), Class II, with primary product code IYN and subsequent codes IYO, ITX and QIH; the review panel and medical specialty are Radiology. SESE means clearance to market, not premarket approval. The public record lists the primary predicate as K223832 (Vivid S70N/S60N) and reference devices including K251169, K243628, K242005, K243620 and several Vivid E95 clearances.

The summary describes three configurations sharing a common operator interface and console electronics, with differences in cleared scope: Vivid Explorer is stated to have indications identical to the Vivid S70N predicate, Vivid Advanced is similar but without 3D/4D imaging modes, and Vivid Focus is similar but not intended for EP lab use, without intracardiac or intraluminal applications or 3D/4D modes, and is stated to match the Vivid T9 (K243628) indications. The database page lists receipt on 04/21/2026 while the summary letter is dated July 31, 2026, and the page indicates a Predetermined Change Control Plan was authorized. The full intended-use text and the scope of that authorized plan are not reproduced in the available excerpts.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261313
Regulatory pathway
510(k) premarket notification
Product code
IYN
Decision code
SESE
Decision date
Sep 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.

Product code
IYN
FDA device class
2

FDA decision timeline

  1. K261313 received

    Application receipt date recorded by FDA.

  2. K261313 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IYN

Product / regulatory recordCompanyPathwayDecision dateSource
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 16, 2026FDA
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 8, 2026FDA
Samsung Medison Co., Ltd.510(k) clearanceOct 8, 2026FDA
GE Medical Systems Ultrasound and Primary care Diagnostics, LLC510(k) clearanceOct 2, 2026FDA
Philips Ultrasound, LLC510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

GE Medical Systems Ultrasound and Primary Care Diagnostics

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Waukesha, WI

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records